(2S)-OMPT (triethylamine), in ethanol:chloroform (1:1), 98%
CAS No. : 1217471-69-6
| Size | Price | Stock |
|---|---|---|
| 100 mg | Get quote | |
| 250 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-120967 |
| M.Wt: | 668.99 |
| Formula: | C34H73N2O6PS |
| Purity: | >98 % |
| Solubility: |
(2S)-OMPT (triethylamine), in ethanol:chloroform (1:1), 98%, Lysophosphatidic acid analogue, is a LPA3 G-protein-coupled receptor agonist. (2S)-OMPT (triethylamine), in ethanol:chloroform (1:1), 98% selectively activates LPA3 G-protein-coupled receptor to trigger downstream cellular signaling events. (2S)-OMPT (triethylamine), in ethanol:chloroform (1:1), 98% induces calcium, IL-6 release in cancer cells and activates MAPK and Akt signaling pathways. (2S)-OMPT (triethylamine), in ethanol:chloroform (1:1), 98% can be used for the research of ovarian cancer[1].
In Vitro:(2S)-OMPT (0.001-10000 nM) (triethylamine), in ethanol:chloroform (1:1), 98% induces calcium release in human ovarian cancer OVCAR3 cells with an EC50 of 9.0 nM[1].
(2S)-OMPT (0.01-1 μM) (triethylamine), in ethanol:chloroform (1:1), 98% activates Akt and MAPK phosphorylation in human ovarian cancer OVCAR3 cells[1].
(2S)-OMPT (0.01-10 μM) (triethylamine), in ethanol:chloroform (1:1), 98% induces IL-6 release in human ovarian cancer OVCAR3 cells[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information- Product Name:
- (2S)-OMPT (triethylamine), in ethanol:chloroform (1:1), 98%
- Cat. No.:
- HY-120967
- Quantity:
Your information is safe with us.